| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2007 | EP1831225A2 Anti-inflammatory pyrazolopyrimidines |
| 09/12/2007 | EP1831223A1 Method for producing l-biopterin |
| 09/12/2007 | EP1831222A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 09/12/2007 | EP1831221A2 Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
| 09/12/2007 | EP1831216A2 Heteroaromatic derivatives useful as anticancer agents |
| 09/12/2007 | EP1831215A1 Pyrido[2,3-d]pyrimidines as anti-inflamatory agents |
| 09/12/2007 | EP1831212A1 Nicotinic acetycholine receptor ligands |
| 09/12/2007 | EP1831211A1 Indazole-carboxamide compounds |
| 09/12/2007 | EP1831210A1 8-aza-bicyclo[3.2.1]octane derivatives with an activity on chemokine ccr5 receptors |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831208A1 Quaternary ammonium salts as m3 antagonists |
| 09/12/2007 | EP1831204A2 Ambruticin vs compounds |
| 09/12/2007 | EP1831203A1 Chroman derivatives and uses thereof in the treatment of cns disorders |
| 09/12/2007 | EP1831202A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 09/12/2007 | EP1831201A1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 09/12/2007 | EP1831200A2 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 09/12/2007 | EP1831199A1 Novel compounds |
| 09/12/2007 | EP1831198A1 Pyridine carboxamide derivatives for use as anticancer agents |
| 09/12/2007 | EP1831197A2 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1831195A1 5-ht7 receptor antagonists |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831193A1 Imidazole derivatives |
| 09/12/2007 | EP1831191A1 Chroman derivatives and their use as 5-ht receptor ligands |
| 09/12/2007 | EP1831189A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831188A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/12/2007 | EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 09/12/2007 | EP1831181A2 Pyrimidine inhibitors of erk protein kinase and uses thereof |
| 09/12/2007 | EP1831177A1 Therapeutic agents |
| 09/12/2007 | EP1831176A2 Mitotic kinesin inhibitors |
| 09/12/2007 | EP1831174A1 Amide derivatives |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831172A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 09/12/2007 | EP1831170A1 Substituted aminopyridines and uses thereof |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1831165A1 4-aminopiperidine derivatives |
| 09/12/2007 | EP1831164A1 Heterocyclic compounds as ccr2b antagonists |
| 09/12/2007 | EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 09/12/2007 | EP1831152A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 09/12/2007 | EP1831151A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino]- 2 -oxoethoxy} phenyl) propanoic acid |
| 09/12/2007 | EP1830900A1 Multi-layer drug delivery device and method of manufacturing same |
| 09/12/2007 | EP1830886A1 Method for stabilizing anti-dementia drug |
| 09/12/2007 | EP1830885A2 Injectable veterinary composition |
| 09/12/2007 | EP1830884A1 Treatment of inflammatory diseases |
| 09/12/2007 | EP1830883A2 Methods for inhibiting a decline in learning and/or memory in animals |
| 09/12/2007 | EP1830880A2 Multi-route administration of immune response modifier compounds |
| 09/12/2007 | EP1830876A2 Treatment for cutaneous metastases |
| 09/12/2007 | EP1830869A1 Method of treatment or prophylaxis |
| 09/12/2007 | EP1830861A2 Antiviral and immunostimulating marine fish oil composition |
| 09/12/2007 | EP1830860A2 Stable non-dihydrate azithromycin oral suspensions |
| 09/12/2007 | EP1830859A2 Methods and compositions for treatment of viral infections |
| 09/12/2007 | EP1830858A2 3, 6-bicyclolides |
| 09/12/2007 | EP1830857A2 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
| 09/12/2007 | EP1830856A2 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |
| 09/12/2007 | EP1830855A1 Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release |
| 09/12/2007 | EP1830854A1 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830852A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 09/12/2007 | EP1830851A2 Rapid disintegrating taste masked compositions and a process for its preparations |
| 09/12/2007 | EP1830850A1 Quinoline derivatives for the treatment of latent tuberculosis |
| 09/12/2007 | EP1830849A1 Fast release dosage forms for antibiotics |
| 09/12/2007 | EP1830848A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 09/12/2007 | EP1830847A1 Treatment for cancer |
| 09/12/2007 | EP1830846A2 Thiazolium compounds and uses thereof |
| 09/12/2007 | EP1830845A2 Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level |
| 09/12/2007 | EP1830844A1 Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor |
| 09/12/2007 | EP1830843A2 Indolidone derivatives for the treatment or prevention of fibrotic diseases |
| 09/12/2007 | EP1830842A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 09/12/2007 | EP1830841A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1830839A2 System and method for power management in mobile units |
| 09/12/2007 | EP1830838A1 Compositions and methods for treating neoplastic diseases |
| 09/12/2007 | EP1830837A2 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 09/12/2007 | EP1830836A1 Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller |
| 09/12/2007 | EP1830835A1 Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pains and method for applying said agent |
| 09/12/2007 | EP1830834A1 Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 09/12/2007 | EP1830833A2 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 09/12/2007 | EP1830832A1 Zinc-containing treatments for hyperphosphatemia |
| 09/12/2007 | EP1830831A2 Pharmaceutical formulations of gallium salts |
| 09/12/2007 | EP1830830A2 Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| 09/12/2007 | EP1830829A1 Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae |
| 09/12/2007 | EP1830828A2 Use of methyl pyruvate to increase cellular energy production downstream of glycolysis |
| 09/12/2007 | EP1830827A2 Perfluorocarbon liquids as carcinogen |
| 09/12/2007 | EP1830826A2 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 09/12/2007 | EP1830825A1 Use of a compound capable of increasing glutathione level in melanocytes for treating canities |
| 09/12/2007 | EP1830824A1 Nanoparticle composition and methods for synthesis thereof |
| 09/12/2007 | EP1830823A2 Stable oral benzimidazole compositions and process of preparation thereof |
| 09/12/2007 | EP1830822A1 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| 09/12/2007 | EP1830819A1 Stable pharmaceutical composition comprising amoxicillin and clavulanic acid |
| 09/12/2007 | EP1830817A1 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
| 09/12/2007 | EP1830816A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| 09/12/2007 | EP1830808A1 Plastic bottle for oxaliplatin solution |
| 09/12/2007 | EP1830807A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 09/12/2007 | EP1830805A2 Compositions comprising polymeric emulsifiers and methods of using same |
| 09/12/2007 | EP1830803A2 Medicament for hygienic application inside the ear |
| 09/12/2007 | EP1830801A2 Drop preparations comprising dimetindene |
| 09/12/2007 | EP1830755A2 Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chitosan |
| 09/12/2007 | EP1830648A2 Treatment using d-threo methylphenidate |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1696741B1 Use of hydroxyoleic acid and related compounds as functional food additives |